THE interest of those concerned in any way with the provision of protection against inhalation hazards, especially those associated with work with radioactive materials, has been stimulated by the ...

Adjuvant therapy with camrelizumab significantly improved 3-year event-free survival in patients with locoregionally advanced nasopharyngeal carcinoma compared with observation, according to ...